MIRA Pharmaceuticals, Inc.MIRANASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.97% | +4.49% | -15.54% | +14.92% | +27.89% |
| Weighted Average Shares Diluted Growth | +1.97% | +4.49% | -15.54% | +14.92% | +27.89% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -52.69% | -40.74% | -63.23% | -71.21% | +78.91% |
| Book Value per Share Growth | -56.81% | -51.87% | -51.46% | -77.65% | +65.18% |
| Debt Growth | -100.00% | -100.00% | -100.00% | +0.00% | +0.00% |
| R&D Expense Growth | +5.14% | +122.52% | -58.75% | -19.25% | -61.34% |
| SG&A Expenses Growth | -52.71% | -40.94% | +48.20% | -5.94% | -10.83% |